Evolus Announces First Shipment of Jeuveau™ (prabotulinumtoxinA-xvfs) to Customers in the United States


You May Also Like

February is American Heart Month

Whittier, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- In honor of American Heart Month, ...

VistaGen Therapeutics Issued Two Key U.S. Patents for Treatment of Depression with AV-101

SOUTH SAN FRANCISCO, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ:VTGN), ...